Here are highlights from the discussion:
1. Experts discussed the use of Stretta in GERD after bariatric surgery; Stretta in treating laryngopharyngeal reflux; and Stretta for GERD after anti-reflux surgery.
2. In all three scenarios Stretta therapy proved successful.
3. Additionally, according to a Mederi Therapeutics infographic, 30 percent of patients, who are refractory to PPIs, don’t get complete relief and are concerned about long-term medications. Also, 42 percent of anti-reflux surgery patients have GERD recur after 10 years.
More articles on GI/endoscopy:
4 things to know about scope care company Ruhof
9 GI physicians receive AGA Annual Recognition Awards
Olympus sets aside $450M for expected settlement, EndoChoice launches IPO of 6.25M shares & more – 6 GI/endoscopy company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
